Identifying gaps and opportunities in myeloma care: results from the “Opinions in myeloma” workshops – IMS 2025
Published:
The workshops also revealed a widespread willingness among clinicians to enroll patients in clinical trials, especially those with high-risk or heavily pretreated myeloma. Yet trial enrollment was often obstructed by logistical and resource barriers — particularly in community settings. Limited research staff, restricted trial hours, inadequate equipment, and patient-related challenges such as transport and time commitment all hindered participation.
Sign up and become a member of the Myeloma UK HCP Hub
Access exclusive content like this and join in the conversation.
Already have an account?